Amicus Therapeutics Inc and the University of Pennsylvania Expansion of Gene Therapy Collaboration - Call Transcript
Good day, ladies and gentlemen, and welcome to the Amicus Therapeutics and the University of Pennsylvania expansion of gene therapy collaboration conference call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to introduce your host for today's conference, Ms. Sara Pellegrino, Vice President, Investor Relations and Corporate Communications. Ma'am, you may begin.
Good morning. Thank you for joining our conference call to discuss the Amicus Therapeutics' expanded gene therapy collaboration with the University of Pennsylvania. Speaking on today's call, we have John Crowley, Chairman and Chief Executive Officer of Amicus; Dr. Jim Wilson of the Gene Therapy Program in the Perelman School of Medicine at Penn; and Dr. Hung Do, Chief Science Officer at Amicus. Also joining for Q&A from Amicus are: Bradley Campbell, President and Chief Operating Officer; Daphne Quimi, Chief Financial Officer; Dr. Jeff Castelli, Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |